Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice.

Liu, Chao Lien; Ye, Peiqing; Lin, Jacqueline; Butts, Chérie L; Miao, Carol H

Liu, Chao Lien; Ye, Peiqing; Lin, Jacqueline; Butts, Chérie L; Miao, Carol H.

Afiliação

Liu CL; Center for Immunity and Immunotherapies, Seattle Children's Research Institute , Seattle, WA , USA ; School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University , Taipei , Taiwan.
Ye P; Center for Immunity and Immunotherapies, Seattle Children's Research Institute , Seattle, WA , USA.
Lin J; Center for Immunity and Immunotherapies, Seattle Children's Research Institute , Seattle, WA , USA.
Butts CL; Biogen Idec, Inc. , Weston, MA , USA.
Miao CH; Center for Immunity and Immunotherapies, Seattle Children's Research Institute , Seattle, WA , USA ; Department of Pediatrics, University of Washington , Seattle, WA , USA.

Front Immunol ; 4: 502, 2014 Jan 06.

Article em En | MEDLINE | ID: mdl-24432019

Palavras-chave

B-cell depletion; anti-CD20; factor VIII; hemophilia; immunomodulation; tolerance induction

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Taiwan